Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen : data from the PRECISION trial

Neville D. Yeomans, David Y. Graham, Qiuqing Wang, Kathy Wolski, Jeffrey Borer, M. Elaine Husni, Peter Libby, A. Michael Lincoff, Thomas Lüscher, Lisa M. Wisniewski, Warren Bao, Chris Walker, Steven E. Nissen

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

To the Editor: We read with interest the paper by Hung et al.[1] “Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan”. The authors found an odds ratio of 5.6 (95% CI 3.33–9.46) for developing acute pancreatitis in subjects taking celecoxib compared with non-users. Their study was not designed to assess whether the coxib associated with a different risk of pancreatitis than non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs).
Original languageEnglish
Pages (from-to)1053-1054
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume113
DOIs
Publication statusPublished - 2018

Keywords

  • celecoxib
  • pancreatitis

Fingerprint

Dive into the research topics of 'Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen : data from the PRECISION trial'. Together they form a unique fingerprint.

Cite this